| Document Date: 2015-04-13 04:15:44
Open Document File Size: 820,04 KBShare Result on Facebook
City Geneva / London / / Company AEs / Chair European Biosimilars Group / / / IndustryTerm medicinal product / safety surveillance systems / healthcare providers / / MedicalTreatment medication errors / / Organization World Health Organization / European Union / WHO INN Office / / Person Sandoz Biopharmaceuticals / Sabine Brosch / Joerg Windisch / / Position Chief Science Officer / / Product Somatropin BS S.C. Injection / Omnitrope / / Technology alpha / bar code / S/N / /
SocialTag |
Considerations on WHO’s BQ Proposal Joerg Windisch, PhD, Chair European Biosimilars Group (EBG) Chief Science Officer, Sandoz Biopharmaceuticals 60th INN Consultation WHO, Geneva, April 13th, 2015